Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

OBJECTIVES: To perform a literature review and develop recommendations for the use of rituximab in ANCA-associated vasculitis. METHODS: A committee of experts (five rheumatologists, five nephrologists and one paediatrician) conducted a modified Delphi exercise to identify five topics for a systemat...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Guerry, M, Brogan, P, Bruce, I, D'Cruz, D, Harper, L, Luqmani, R, Pusey, C, Salama, A, Scott, D, Savage, C, Watts, R, Jayne, DR
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2012

समान संसाधन

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
द्वारा: Flossmann, O, और अन्य
प्रकाशित: (2006)

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
द्वारा: Latimer, N, और अन्य
प्रकाशित: (2014)

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
द्वारा: Latimer, N, और अन्य
प्रकाशित: (2014)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
द्वारा: Basu, N, और अन्य
प्रकाशित: (2014)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
द्वारा: Hellmich, B, और अन्य
प्रकाशित: (2007)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
द्वारा: Robson, J, और अन्य
प्रकाशित: (2017)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
द्वारा: Pearce, F, और अन्य
प्रकाशित: (2017)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
द्वारा: Mukhtyar, C, और अन्य
प्रकाशित: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
द्वारा: Mukhtyar, C, और अन्य
प्रकाशित: (2008)

The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV)
द्वारा: Luqmani, R, और अन्य
प्रकाशित: (2017)

Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
द्वारा: Feldmann, M, और अन्य
प्रकाशित: (2006)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
द्वारा: Jones, R, और अन्य
प्रकाशित: (2010)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
द्वारा: Robson, J, और अन्य
प्रकाशित: (2017)

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
द्वारा: Robson, J, और अन्य
प्रकाशित: (2014)

The United Kingdom and Ireland Vasculitis Registry: Cross-sectional data on the first 3195 patients with a focus on anti-neutrophil cytoplasm – associated vasculitis and giant cell arteritis
द्वारा: Luqmani, R, और अन्य
प्रकाशित: (2017)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
द्वारा: Merkel, P, और अन्य
प्रकाशित: (2009)

Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
द्वारा: Jones, R, और अन्य
प्रकाशित: (2009)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
द्वारा: de Groot, K, और अन्य
प्रकाशित: (2009)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
द्वारा: Luqmani, R, और अन्य
प्रकाशित: (2017)

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
द्वारा: Robson, J, और अन्य
प्रकाशित: (2016)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
द्वारा: Walsh, M, और अन्य
प्रकाशित: (2011)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
द्वारा: Morishita, K, और अन्य
प्रकाशित: (2017)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
द्वारा: McLaren, J, और अन्य
प्रकाशित: (2001)

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
द्वारा: Ntatsaki, E, और अन्य
प्रकाशित: (2014)

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
द्वारा: Lapraik, C, और अन्य
प्रकाशित: (2007)

Eular recommendations for vasculitis
द्वारा: Luqmani, R, और अन्य
प्रकाशित: (2007)

Cardiovascular Outcomes Are Worse In Microscopic Polyangiitis Compared To Granulomatosis With Polyangiitis: Data From An Inception Cohort Of Patients With Anti-Neutrophil Cytoplasm Antibody Associated Systemic Vasculitis
द्वारा: Mistry, A, और अन्य
प्रकाशित: (2013)

The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.
द्वारा: McLaren, J, और अन्य
प्रकाशित: (2001)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
द्वारा: De Groot, K, और अन्य
प्रकाशित: (2005)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis
द्वारा: Chand, S, और अन्य
प्रकाशित: (2013)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
द्वारा: Mukhtyar, C, और अन्य
प्रकाशित: (2008)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
द्वारा: Robson, J, और अन्य
प्रकाशित: (2017)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
द्वारा: Talks, S, और अन्य
प्रकाशित: (1994)

A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hospital.
द्वारा: McLaren, J, और अन्य
प्रकाशित: (2000)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
द्वारा: Luqmani, R, और अन्य
प्रकाशित: (2007)

EULAR recommendations for the management of large vessel vasculitis.
द्वारा: Mukhtyar, C, और अन्य
प्रकाशित: (2009)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
द्वारा: Robson, J, और अन्य
प्रकाशित: (2013)

Cardiovascular involvement in primary systemic vasculitis.
द्वारा: Mukhtyar, C, और अन्य
प्रकाशित: (2009)

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
द्वारा: Jayne, DR, और अन्य
प्रकाशित: (1997)

Immunofluorescence (IF) pattern, autoantigens of anti-neutrophil cytoplasmic antibodies (ANCA) and their clinical associations
द्वारा: Masita Arip,, और अन्य
प्रकाशित: (2010)